Company / Inventory
NOVAVAX INC Inventory History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$11.5M
FY2025
5-year range
$8.7M / $41.7M
FY2021-FY2025
Trend
+32.0%
vs FY2024
Sector context
#85 of 105
Health Care
What the data says
NOVAVAX INC's inventory of $12M is lower than 81% of companies in the Health Care sector (FY2025). Declined from $42M to $12M over the past 2 years.
Based on SEC 10-K filings.
$12M in FY2025 with a 3-year CAGR of -32.0%.
Declined from $42M to $12M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -32.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 105This company $11.5M Sector average $885.3M
▼
-98.7% below sector average
Key checks
Key Insights
- 3-year CAGR of -32.0%, indicating a declining trend.
- In FY2025, inventory increased 32.0% year-over-year.
- Ranks #85 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.5M | +32.0% |
| FY2024 | $8.7M | -79.0% |
| FY2023 | $41.7M | +13.7% |
| FY2022 | $36.7M | +313.5% |
| FY2021 | $8.9M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026